Wall Street Experts
ver. ZuMIgo(08/25)
Anebulo Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -10
index |
0 |
1 |
2 |
3 |
4 |
Rok finansowy |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EBIT (mln) |
-0 |
-4 |
-7 |
-12 |
-8 |
EBIT Δ r/r |
0.0% |
1984.7% |
89.0% |
72.5% |
-29.5% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
EBITDA (mln) |
-0 |
-4 |
-7 |
-12 |
-8 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
-0 |
0 |
-0 |
-0 |
0 |
Zysk Netto (mln) |
-0 |
-30 |
-7 |
-12 |
-8 |
Zysk netto Δ r/r |
0.0% |
17229.3% |
-77.5% |
72.2% |
-30.1% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
-0.0074 |
-1.3 |
-0.29 |
-0.47 |
-0.32 |
EPS (rozwodnione) |
-0.0074 |
-1.3 |
-0.29 |
-0.47 |
-0.32 |
Ilośc akcji (mln) |
24 |
23 |
23 |
25 |
26 |
Ważona ilośc akcji (mln) |
24 |
23 |
23 |
25 |
26 |
Waluta |
USD |
USD |
USD |
USD |
USD |